VThunter
a database for single-cell screening of virus target cells in animal kingdom
Blue-and-yellow macaw

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Psittaciformes; Psittacidae; Ara,

Latin Name: Ara ararauna

Tested tissues: PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0063 2021.04 iDrop PBMC Normal 5709 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Adeno-associated virus - 3
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
Adeno-associated virus - 2
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Macrophage : 12.23% ;
PBMC-Erythroid Progenitors : 5.56% ;
PBMC-B cells : 5.03% ;
PBMC-T cells : 3.64% ;
PBMC-Neutrophil : 2.88% ;
Sindbis virus
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
Dengue virus
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
PBMC-Neutrophil : 9.16% ;
PBMC-Macrophage : 1.06% ;
PBMC-T cells : 0.67% ;
PBMC-Platelets : 0.34% ;
PBMC-B cells : 0.30% ;
PBMC-Macrophage : 6.38% ;
PBMC-Erythroid Progenitors : 1.39% ;
PBMC-T cells : 0.89% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.23% ;
Adeno-associated virus - 8
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
Classical swine fever virus
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
Venezuelan equine encephalitis virus
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
Adeno-associated virus 9
PBMC-Macrophage : 95.21% ;
PBMC-B cells : 92.31% ;
PBMC-Endothelial cells : 88.64% ;
PBMC-T cells : 87.54% ;
PBMC-Erythroid Progenitors : 41.67% ;
Lassa mammarenavirus
PBMC-Macrophage : 82.45% ;
PBMC-Neutrophil : 11.26% ;
PBMC-Erythroid Progenitors : 10.42% ;
PBMC-Endothelial cells : 9.09% ;
PBMC-T cells : 8.98% ;
PBMC-Platelets : 10.35% ;
PBMC-Macrophage : 9.04% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-T cells : 3.19% ;
PBMC-Neutrophil : 1.31% ;
PBMC-Macrophage : 6.38% ;
PBMC-Erythroid Progenitors : 1.39% ;
PBMC-T cells : 0.89% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.23% ;
Influenza A virus
PBMC-Macrophage : 73.40% ;
PBMC-Endothelial cells : 15.91% ;
PBMC-T cells : 8.09% ;
PBMC-B cells : 7.10% ;
PBMC-Platelets : 4.21% ;
PBMC-Macrophage : 33.51% ;
PBMC-B cells : 6.51% ;
PBMC-T cells : 4.08% ;
PBMC-Neutrophil : 3.66% ;
PBMC-Endothelial cells : 2.27% ;
PBMC-T cells : 0.82% ;
PBMC-B cells : 0.59% ;
PBMC-Macrophage : 0.00% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.67% ;
PBMC-Platelets : 0.46% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.00% ;
Simian rotavirus A strain RRV
PBMC-Macrophage : 72.87% ;
PBMC-Endothelial cells : 59.09% ;
PBMC-T cells : 54.67% ;
PBMC-B cells : 46.75% ;
PBMC-Neutrophil : 36.39% ;
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
PBMC-Macrophage : 1.60% ;
PBMC-Neutrophil : 0.79% ;
PBMC-B cells : 0.59% ;
PBMC-Platelets : 0.23% ;
PBMC-T cells : 0.07% ;
Coxsackievirus A9
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 1.56% ;
PBMC-B cells : 0.59% ;
PBMC-Neutrophil : 0.52% ;
PBMC-Platelets : 0.46% ;
West Nile virus
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
Human gammaherpesvirus 8
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
PBMC-Macrophage : 1.60% ;
PBMC-B cells : 0.30% ;
PBMC-T cells : 0.22% ;
PBMC-Platelets : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Human mastadenovirus C
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
PBMC-Macrophage : 2.66% ;
PBMC-T cells : 0.07% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human betaherpesvirus 5
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
PBMC-Endothelial cells : 2.27% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-T cells : 0.82% ;
PBMC-B cells : 0.59% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human parechovirus 1
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
Coxsackievirus B1
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 1.56% ;
PBMC-B cells : 0.59% ;
PBMC-Neutrophil : 0.52% ;
PBMC-Platelets : 0.46% ;
Foot-and-mouth disease virus
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 1.56% ;
PBMC-B cells : 0.59% ;
PBMC-Neutrophil : 0.52% ;
PBMC-Platelets : 0.46% ;
PBMC-Macrophage : 1.06% ;
PBMC-T cells : 0.30% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Human alphaherpesvirus 1
PBMC-Macrophage : 72.34% ;
PBMC-Endothelial cells : 13.64% ;
PBMC-Neutrophil : 10.73% ;
PBMC-B cells : 5.92% ;
PBMC-T cells : 5.86% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 1.56% ;
PBMC-B cells : 0.59% ;
PBMC-Neutrophil : 0.52% ;
PBMC-Platelets : 0.46% ;
PBMC-Macrophage : 1.06% ;
PBMC-T cells : 0.30% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.53% ;
PBMC-T cells : 0.15% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Equid alphaherpesvirus 1
PBMC-Macrophage : 70.21% ;
PBMC-B cells : 63.31% ;
PBMC-T cells : 52.45% ;
PBMC-Neutrophil : 40.58% ;
PBMC-Endothelial cells : 31.82% ;
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
Bovine leukemia virus
PBMC-Macrophage : 69.15% ;
PBMC-Endothelial cells : 43.18% ;
PBMC-Neutrophil : 38.74% ;
PBMC-T cells : 24.33% ;
PBMC-B cells : 20.71% ;
Human immunodeficiency virus 1
PBMC-B cells : 64.79% ;
PBMC-Macrophage : 44.68% ;
PBMC-T cells : 34.79% ;
PBMC-Endothelial cells : 27.27% ;
PBMC-Neutrophil : 11.26% ;
PBMC-T cells : 9.57% ;
PBMC-Macrophage : 1.60% ;
PBMC-Erythroid Progenitors : 0.69% ;
PBMC-Platelets : 0.68% ;
PBMC-B cells : 0.30% ;
Feline immunodeficiency virus
PBMC-B cells : 64.79% ;
PBMC-Macrophage : 44.68% ;
PBMC-T cells : 34.79% ;
PBMC-Endothelial cells : 27.27% ;
PBMC-Neutrophil : 11.26% ;
PBMC-T cells : 0.22% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Human immunodeficiency virus 2
PBMC-B cells : 64.79% ;
PBMC-Macrophage : 44.68% ;
PBMC-T cells : 34.79% ;
PBMC-Endothelial cells : 27.27% ;
PBMC-Neutrophil : 11.26% ;
PBMC-T cells : 9.57% ;
PBMC-Macrophage : 1.60% ;
PBMC-Erythroid Progenitors : 0.69% ;
PBMC-Platelets : 0.68% ;
PBMC-B cells : 0.30% ;
Human metapneumovirus
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
Human rotavirus strain WA
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Macrophage : 1.60% ;
PBMC-Neutrophil : 0.79% ;
PBMC-B cells : 0.59% ;
PBMC-Platelets : 0.23% ;
PBMC-T cells : 0.07% ;
Echovirus E8
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Macrophage : 1.60% ;
PBMC-Neutrophil : 0.79% ;
PBMC-B cells : 0.59% ;
PBMC-Platelets : 0.23% ;
PBMC-T cells : 0.07% ;
Mammalian orthoreovirus
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Macrophage : 0.53% ;
PBMC-T cells : 0.07% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Human parvovirus B19
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
Echovirus E1
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Macrophage : 1.60% ;
PBMC-Neutrophil : 0.79% ;
PBMC-B cells : 0.59% ;
PBMC-Platelets : 0.23% ;
PBMC-T cells : 0.07% ;
Human gammaherpesvirus 4
PBMC-Macrophage : 63.83% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Platelets : 30.94% ;
PBMC-T cells : 24.41% ;
PBMC-B cells : 13.91% ;
PBMC-Macrophage : 1.06% ;
PBMC-B cells : 0.30% ;
PBMC-T cells : 0.22% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Hepacivirus C
PBMC-Endothelial cells : 59.09% ;
PBMC-Macrophage : 54.79% ;
PBMC-T cells : 15.21% ;
PBMC-B cells : 6.51% ;
PBMC-Neutrophil : 4.19% ;
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
PBMC-Neutrophil : 9.16% ;
PBMC-Macrophage : 1.06% ;
PBMC-T cells : 0.67% ;
PBMC-Platelets : 0.34% ;
PBMC-B cells : 0.30% ;
PBMC-Macrophage : 3.19% ;
PBMC-Endothelial cells : 2.27% ;
PBMC-T cells : 1.11% ;
PBMC-Platelets : 0.57% ;
PBMC-B cells : 0.30% ;
PBMC-Macrophage : 1.60% ;
PBMC-B cells : 0.59% ;
PBMC-T cells : 0.22% ;
PBMC-Platelets : 0.11% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Macrophage : 1.60% ;
PBMC-B cells : 1.18% ;
PBMC-Neutrophil : 0.52% ;
PBMC-T cells : 0.30% ;
PBMC-Platelets : 0.11% ;
PBMC-T cells : 0.82% ;
PBMC-B cells : 0.59% ;
PBMC-Macrophage : 0.00% ;
PBMC-Endothelial cells : 0.00% ;
Xenotropic murine leukemia virus
PBMC-Macrophage : 37.77% ;
PBMC-T cells : 12.61% ;
PBMC-B cells : 11.24% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 4.71% ;
Polytropic murine leukemia virus
PBMC-Macrophage : 37.77% ;
PBMC-T cells : 12.61% ;
PBMC-B cells : 11.24% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 4.71% ;
Machupo mammarenavirus
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
Mouse mammary tumor virus
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
Argentinian mammarenavirus
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
Feline panleukopenia virus
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
Guanarito mammarenavirus
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
Canine parvovirus
PBMC-Erythroid Progenitors : 36.11% ;
PBMC-Endothelial cells : 22.73% ;
PBMC-B cells : 15.98% ;
PBMC-Macrophage : 9.57% ;
PBMC-T cells : 7.12% ;
Vesicular stomatitis virus
PBMC-Macrophage : 33.51% ;
PBMC-B cells : 6.51% ;
PBMC-T cells : 4.08% ;
PBMC-Neutrophil : 3.66% ;
PBMC-Endothelial cells : 2.27% ;
Hantaan orthohantavirus
PBMC-Platelets : 32.08% ;
PBMC-Macrophage : 14.89% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 3.93% ;
PBMC-T cells : 2.45% ;
Human mastadenovirus B
PBMC-Macrophage : 31.38% ;
PBMC-B cells : 0.89% ;
PBMC-Platelets : 0.11% ;
PBMC-T cells : 0.07% ;
PBMC-Endothelial cells : 0.00% ;
Chikungunya virus
PBMC-Macrophage : 29.26% ;
PBMC-Endothelial cells : 15.91% ;
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.64% ;
PBMC-Erythroid Progenitors : 6.94% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
Ebola virus
PBMC-Macrophage : 27.13% ;
PBMC-Neutrophil : 8.12% ;
PBMC-T cells : 3.64% ;
PBMC-B cells : 3.55% ;
PBMC-Erythroid Progenitors : 2.08% ;
PBMC-Macrophage : 8.51% ;
PBMC-B cells : 0.30% ;
PBMC-Platelets : 0.23% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Macrophage : 6.38% ;
PBMC-Erythroid Progenitors : 1.39% ;
PBMC-T cells : 0.89% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.23% ;
Severe acute respiratory syndrome coronavirus 2
PBMC-Endothelial cells : 25.00% ;
PBMC-Platelets : 5.57% ;
PBMC-Macrophage : 4.26% ;
PBMC-B cells : 3.85% ;
PBMC-T cells : 1.71% ;
PBMC-Macrophage : 1.60% ;
PBMC-B cells : 0.59% ;
PBMC-T cells : 0.22% ;
PBMC-Platelets : 0.11% ;
PBMC-Endothelial cells : 0.00% ;
Human papillomavirus type 16
PBMC-Platelets : 18.66% ;
PBMC-Macrophage : 5.85% ;
PBMC-Endothelial cells : 4.55% ;
PBMC-T cells : 2.89% ;
PBMC-Neutrophil : 2.09% ;
PBMC-Macrophage : 11.70% ;
PBMC-Neutrophil : 2.88% ;
PBMC-T cells : 2.67% ;
PBMC-B cells : 1.48% ;
PBMC-Erythroid Progenitors : 0.69% ;
Amphotropic murine leukemia virus
PBMC-Endothelial cells : 15.91% ;
PBMC-B cells : 11.54% ;
PBMC-Macrophage : 4.79% ;
PBMC-Neutrophil : 1.83% ;
PBMC-T cells : 1.48% ;
Feline leukemia virus strain B/lambda-B1
PBMC-Endothelial cells : 15.91% ;
PBMC-B cells : 11.54% ;
PBMC-Macrophage : 4.79% ;
PBMC-Neutrophil : 1.83% ;
PBMC-T cells : 1.48% ;
PBMC-Erythroid Progenitors : 11.11% ;
PBMC-Macrophage : 7.45% ;
PBMC-T cells : 7.12% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-B cells : 4.44% ;
Gibbon ape leukemia virus
PBMC-Endothelial cells : 15.91% ;
PBMC-B cells : 11.54% ;
PBMC-Macrophage : 4.79% ;
PBMC-Neutrophil : 1.83% ;
PBMC-T cells : 1.48% ;
PBMC-Erythroid Progenitors : 11.11% ;
PBMC-Macrophage : 7.45% ;
PBMC-T cells : 7.12% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-B cells : 4.44% ;
Enterovirus A71
PBMC-Endothelial cells : 13.64% ;
PBMC-Macrophage : 4.26% ;
PBMC-T cells : 3.86% ;
PBMC-Neutrophil : 0.52% ;
PBMC-B cells : 0.30% ;
PBMC-Macrophage : 9.57% ;
PBMC-B cells : 1.18% ;
PBMC-Neutrophil : 1.05% ;
PBMC-T cells : 1.04% ;
PBMC-Platelets : 0.46% ;
Varicella Zoster Virus
PBMC-Endothelial cells : 13.64% ;
PBMC-B cells : 7.69% ;
PBMC-Macrophage : 7.45% ;
PBMC-Erythroid Progenitors : 6.94% ;
PBMC-T cells : 6.08% ;
Human alphaherpesvirus 3
PBMC-Endothelial cells : 13.64% ;
PBMC-B cells : 7.69% ;
PBMC-Macrophage : 7.45% ;
PBMC-Erythroid Progenitors : 6.94% ;
PBMC-T cells : 6.08% ;
Coxsackievirus B6
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Human mastadenovirus A
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Coxsackievirus B5
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Human mastadenovirus E
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Coxsackievirus B2
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Human mastadenovirus F
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Coxsackievirus B3
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Human mastadenovirus D
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Coxsackievirus B4
PBMC-Macrophage : 12.23% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Porcine reproductive and respiratory syndrome virus
PBMC-Macrophage : 11.70% ;
PBMC-Neutrophil : 2.88% ;
PBMC-T cells : 2.67% ;
PBMC-B cells : 1.48% ;
PBMC-Erythroid Progenitors : 0.69% ;
PBMC-Macrophage : 3.72% ;
PBMC-T cells : 0.30% ;
PBMC-B cells : 0.30% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Simian sarcoma-associated virus
PBMC-Erythroid Progenitors : 11.11% ;
PBMC-Macrophage : 7.45% ;
PBMC-T cells : 7.12% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-B cells : 4.44% ;
Lymphocytic choriomeningitis mammarenavirus
PBMC-Platelets : 10.35% ;
PBMC-Macrophage : 9.04% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-T cells : 3.19% ;
PBMC-Neutrophil : 1.31% ;
PBMC-Macrophage : 6.38% ;
PBMC-Erythroid Progenitors : 1.39% ;
PBMC-T cells : 0.89% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.23% ;
Latino mammarenavirus
PBMC-Platelets : 10.35% ;
PBMC-Macrophage : 9.04% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-T cells : 3.19% ;
PBMC-Neutrophil : 1.31% ;
Oliveros mammarenavirus
PBMC-Platelets : 10.35% ;
PBMC-Macrophage : 9.04% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-T cells : 3.19% ;
PBMC-Neutrophil : 1.31% ;
Coxsackievirus A16
PBMC-Macrophage : 9.57% ;
PBMC-B cells : 1.18% ;
PBMC-Neutrophil : 1.05% ;
PBMC-T cells : 1.04% ;
PBMC-Platelets : 0.46% ;
Simian immunodeficiency virus
PBMC-T cells : 9.57% ;
PBMC-Macrophage : 1.60% ;
PBMC-Erythroid Progenitors : 0.69% ;
PBMC-Platelets : 0.68% ;
PBMC-B cells : 0.30% ;
Human betaherpesvirus 7
PBMC-T cells : 9.57% ;
PBMC-Macrophage : 1.60% ;
PBMC-Erythroid Progenitors : 0.69% ;
PBMC-Platelets : 0.68% ;
PBMC-B cells : 0.30% ;
Marburg marburgvirus
PBMC-Macrophage : 8.51% ;
PBMC-B cells : 0.30% ;
PBMC-Platelets : 0.23% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Macrophage : 6.38% ;
PBMC-Erythroid Progenitors : 1.39% ;
PBMC-T cells : 0.89% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.23% ;
Jaagsiekte sheep retrovirus
PBMC-Macrophage : 7.45% ;
PBMC-Endothelial cells : 6.82% ;
PBMC-Neutrophil : 2.09% ;
PBMC-B cells : 1.78% ;
PBMC-T cells : 0.89% ;
Japanese encephalitis virus
PBMC-Platelets : 6.60% ;
PBMC-Macrophage : 3.19% ;
PBMC-T cells : 0.37% ;
PBMC-Neutrophil : 0.26% ;
Zika virus
PBMC-Macrophage : 6.38% ;
PBMC-Erythroid Progenitors : 1.39% ;
PBMC-T cells : 0.89% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.23% ;
Feline leukemia virus strain C/FA27
PBMC-Platelets : 5.80% ;
PBMC-Macrophage : 3.19% ;
PBMC-Endothelial cells : 2.27% ;
PBMC-T cells : 0.96% ;
PBMC-B cells : 0.89% ;
Respiratory syncytial virus
PBMC-T cells : 5.27% ;
PBMC-Endothelial cells : 2.27% ;
PBMC-Erythroid Progenitors : 0.69% ;
PBMC-B cells : 0.59% ;
PBMC-Macrophage : 0.53% ;
Middle East respiratory syndrome-related coronavirus
PBMC-Endothelial cells : 4.55% ;
PBMC-T cells : 0.67% ;
PBMC-Macrophage : 0.53% ;
PBMC-B cells : 0.30% ;
PBMC-Erythroid Progenitors : 0.00% ;
Canine coronavirus
PBMC-Endothelial cells : 2.27% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
Infectious bronchitis virus
PBMC-Endothelial cells : 2.27% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
Rabies lyssavirus
PBMC-Endothelial cells : 2.27% ;
PBMC-B cells : 0.30% ;
PBMC-T cells : 0.07% ;
PBMC-Platelets : 0.00% ;
PBMC-Macrophage : 0.00% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Feline coronavirus
PBMC-Endothelial cells : 2.27% ;
PBMC-B cells : 0.00% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Macrophage : 0.00% ;
PBMC-Platelets : 0.00% ;
Human coronavirus 229E
PBMC-Endothelial cells : 2.27% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
Porcine epidemic diarrhea virus
PBMC-Endothelial cells : 2.27% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Transmissible gastroenteritis virus
PBMC-Endothelial cells : 2.27% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
JC polyomavirus
PBMC-Platelets : 1.71% ;
PBMC-T cells : 0.07% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Hepatitis E virus
PBMC-T cells : 1.48% ;
PBMC-Macrophage : 0.53% ;
PBMC-B cells : 0.30% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;
Encephalomyocarditis virus
PBMC-T cells : 1.48% ;
PBMC-B cells : 0.89% ;
PBMC-Macrophage : 0.53% ;
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.11% ;
Ecotropic murine leukemia virus
PBMC-B cells : 1.48% ;
PBMC-Macrophage : 0.53% ;
PBMC-T cells : 0.52% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Phocine morbillivirus
PBMC-B cells : 1.18% ;
PBMC-T cells : 1.11% ;
PBMC-Macrophage : 1.06% ;
PBMC-Platelets : 0.23% ;
PBMC-Neutrophil : 0.00% ;
Canine morbillivirus
PBMC-B cells : 1.18% ;
PBMC-T cells : 1.11% ;
PBMC-Macrophage : 1.06% ;
PBMC-Platelets : 0.23% ;
PBMC-Neutrophil : 0.00% ;
Measles morbillivirus
PBMC-B cells : 1.18% ;
PBMC-T cells : 1.11% ;
PBMC-Macrophage : 1.06% ;
PBMC-Platelets : 0.23% ;
PBMC-Neutrophil : 0.00% ;
Rinderpest morbillivirus
PBMC-B cells : 1.18% ;
PBMC-T cells : 1.11% ;
PBMC-Macrophage : 1.06% ;
PBMC-Platelets : 0.23% ;
PBMC-Endothelial cells : 0.00% ;
Coxsackievirus A10
PBMC-T cells : 1.11% ;
PBMC-Macrophage : 0.53% ;
PBMC-Platelets : 0.23% ;
PBMC-B cells : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Hendra henipavirus
PBMC-Macrophage : 1.06% ;
PBMC-T cells : 0.82% ;
PBMC-B cells : 0.59% ;
PBMC-Platelets : 0.11% ;
PBMC-Endothelial cells : 0.00% ;
Nipah henipavirus
PBMC-Macrophage : 1.06% ;
PBMC-T cells : 0.82% ;
PBMC-B cells : 0.59% ;
PBMC-Platelets : 0.11% ;
PBMC-Neutrophil : 0.00% ;
Sin Nombre orthohantavirus
PBMC-Platelets : 0.57% ;
PBMC-T cells : 0.45% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Andes orthohantavirus
PBMC-Platelets : 0.57% ;
PBMC-T cells : 0.45% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human alphaherpesvirus 2
PBMC-Macrophage : 0.53% ;
PBMC-T cells : 0.15% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Bovine alphaherpesvirus 1
PBMC-Macrophage : 0.53% ;
PBMC-T cells : 0.15% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Suid alphaherpesvirus 1
PBMC-Macrophage : 0.53% ;
PBMC-T cells : 0.15% ;
PBMC-Neutrophil : 0.00% ;
Onyong-nyong virus
PBMC-Neutrophil : 0.26% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
Rhinovirus C
PBMC-Neutrophil : 0.26% ;
PBMC-T cells : 0.07% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Enterovirus D68
PBMC-Neutrophil : 0.26% ;
PBMC-T cells : 0.15% ;
PBMC-Erythroid Progenitors : 0.00% ;
Ross River virus
PBMC-Neutrophil : 0.26% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
Mayaro virus
PBMC-Neutrophil : 0.26% ;
PBMC-Endothelial cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-T cells : 0.00% ;
Human betaherpesvirus 6B
PBMC-T cells : 0.22% ;
PBMC-Neutrophil : 0.00% ;
PBMC-Platelets : 0.00% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China